Kontafarma China Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs in Mainland China, Singapore, Taiwan, and internationally. It operates in Pharmaceutical Business and Fitness Business segments. The company offers chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers; operates in the franchise business; and provides consultation services for fitness and health activities. It also researches and develops medical products; and offers corporate advisory services. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
Stock data | 2024 | Change |
---|---|---|
Price | $0.0036024909937728373 | N/A |
Market Cap | $20.13M | N/A |
Shares Outstanding | 5.59B | N/A |
Employees | 715.00 | N/A |